50% off Premium Yearly

TSE:HMMJ
This summary was created by AI, based on 1 opinions in the last 12 months.
Horizon Medical Marijuana (HMMJ-T) has captured the attention of several experts, particularly regarding its potential for significant growth. There is optimism surrounding the possibility of new banking legislation that could greatly affect the company's fortunes, with some experts noting strong bipartisan support for such a change. The stock is characterized by high volatility, suggesting that it can experience rapid changes in price, which may present both risks and opportunities for investors. The consensus is that Horizon Medical Marijuana could be a standout performer, with the potential to become a multi-bagger investment, possibly offering returns that could multiply by 2, 4, 5, or even 10 times its current value. This combination of legislative prospects and market dynamics makes it a compelling option for investors seeking substantial gains in the marijuana sector.
It is purely based on where you think it will go in the next while but it could be a good bet. It is risky and only for the riskiest investors. There could be pull backs equal in magnitude to the run ups we have seen. There are not large blocks transacting regularly so it is a home grown retail investor interest. It is definitely a growing industry.
Horizons did a good job on marketing by coming up with this ETF. Marijuana will probably do very, very well. Specialty ETF’s tend to be expensive. The management expense ratio on this one is around 70 or 75 basis points, which is kind of a premium. On something like this he would be very tempted to just buy individual stocks.
Something he is not looking at closely. The rise in marijuana stocks is new, and reminds him a lot of the rise of some of the emerging technology stocks back in 1999. It may pay off well, but the industry is so uncertain at this point. The rules on marijuana have yet to be put in place. This is a trader’s vehicle, not necessarily an investor’s vehicle. Not an area he would be investing in.
This dropped a great deal, and may have hit bottom. The long-term for the industry is still very positive. This only has 15-17 names in it, and 3 of them make up 10% each. A diversified way to get exposure to an asset class, which everyone is talking about. Rather than betting the farm on one company or another, buy the ETF rather than trying to decide which company is going to be the winner or loser.
Had a hard look at this ETF. There are some fairly well-established companies, plus a whole bunch of little guys. Apparently, in some of the smaller companies, the principals have been busily selling their shares as fast as they can. The worst thing you can see in any situation is people actually stepping back and selling their shares. Stay back until the dust settles a little. See what the regulations will be.
An ETF is a natural to diversify the business risks such as crop failures. One problem is that this has 4 components that are not Canadian LPs. They have a fertilizer company which focuses on marijuana growing. They also have 3 cannabinoid research companies. You really have to follow these 4 companies, as they represent almost 40% of the ETF. He is leery of this ETF, and it is below the issue price.